— Corporate governance — Information policy
Information policy
According to Art. 38 of the Articles of Association (on medmix.swiss/en/Investors/Governance; under Downloads), the announcements of medmix Ltd are published in the Swiss Official Gazette of Commerce. In addition, notices to registered shareholders in those cases prescribed by law shall take place in writing to the shareholder’s address last known to the company.
medmix Ltd reports on its financial results every half year. In each case, it also comments on business performance and outlook. In addition, the company reports on price-related facts on an ongoing basis (ad hoc publications). The reporting referred to in the compensation report (including the respective references to the financial reporting section) complies with the recommendations on the content of the compensation report as laid out in section 38 of Appendix 1 to the Swiss Code of Best Practice for Corporate Governance.
Key dates in 2023
- February 22: Annual results 2022
- April 28: Annual General Meeting 2023
- July 20: Mid-year results 2023
These dates and any changes can be viewed on medmix.swiss/en/Investors/Financial-Reports. Media releases (sent via e-mail) can be subscribed to on https://www.medmix.swiss/news/media-release-subscription. Further information is available on medmix.swiss, or by contacting Investor Relations at investorrelations@medmix.com.
The contact address for Investor Relations is:
medmix Ltd
Investor Relations
Neuhofstrasse 20
6340 Baar
Switzerland
+41417237375
Investorrelations@medmix.com
Blackout periods
Generally and regardless of whether any inside information exists or not, pursuant to medmix’ Securities Trading, Public Disclosure and Reporting Regulations, the trading in medmix Ltd securities is prohibited for (a) the members of the Board of Directors and the Executive Committee, (b) any staff reporting to any member of the Executive Committee, (c) members of Group Finance, Group Planning and M&A, Group Communications and Investor Relations, and (d) any external advisor having access to inside information in connection with medmix Ltd’s financial reporting, during the following periods: the periods starting on January 1 and July 1 up to and including the trading day of the public releases of the respective full-year or half-year reports (if published prior to 7:30 am CET) or the following trading day (if published between 5:40 pm and midnight CET).
Under certain circumstances (in particular, in case of personal hardship), the company may allow exceptions to a blackout period upon reasoned request by an employee, provided that such employee is not in possession of any inside information. Such exceptions must be issued in writing with a copy to the employee’s file.